Mid-Cap Healthcare Companies LifeStance Health Group and PACS Group Listed on Nasdaq
1 report, 1 independent
Updated Thu 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
LifeStance Health Group and PACS Group are both identified as mid-cap healthcare companies that have been newly listed on Nasdaq. A comparison of the two companies shows that PACS Group has higher revenue and earnings than LifeStance Health Group. Furthermore, PACS Group is trading at a lower price-to-earnings ratio than LifeStance Health Group.
From themarketsdaily.com
Why it matters
Analysts suggest PACS Group is more favorable than LifeStance Health Group, citing its higher probable upside and lower valuation. Institutional ownership differs significantly between the two firms, with 85.5% of LifeStance Health Group shares owned by institutional investors.
From themarketsdaily.com
Who's involved
- NasdaqThe American fully electronic stock exchange where the companies are listed
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- Korro Bio, Inc. and Wellgistics Health were listed on the Nasdaq stock exchange on July 1, 2026.
- Life360 and Freshworks, two mid-cap technology companies, were listed on the electronic stock exchange on September 14, 2026, and are receiving analyst ratings.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- Amesite, listed on Nasdaq, is targeting post-acute care organizations with its platform.
- Cardiol Therapeutics Inc. is listed on Nasdaq and is developing therapy for an FDA-approved indication.